CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
- 424B3 Offering Prospectus
- 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 75,680 shares at $1.69 ($127,899)
- 4 Grant or award Director acquired 42,254 shares (grant or award)
- 4 Grant or award Director acquired 42,254 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 51,830 shares (grant or award)
- 4 Open-market buy President & CEO bought 10,000 shares at $1.78 ($17,800)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 8-K Event Shareholder vote results
Page 8 of 26 · 511 filings